[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fkrQ0wu9PmyxSbSHg2UyWpgMB7TFekYRoYODFBFJJ4lE":8,"$fe-7zXDl_GbqYo6snWZjoLIJX7WeDVdwbkogD_T5NB60":55,"$fYg9_r_ddFM-DkI_ICL_QxHHpPtYKWqzwOrI1PR8Vv-k":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},61753,868960,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//qToouzd3wNZJDyz176JvWbOwPLYeq3AU.png","王淑倩","浙江大学医学院附属第一医院","甲状腺乳腺外科","副主任医师",29,0,"乳腺癌治疗用药实用指南：高级别导管原位癌与浸润性导管癌II级","","https://ystcdn.venuertc.com/venue/AI/d6826be0-1f40-4742-978e-c0051509d1b3.jpg","\u003Cdiv class=\"drug-guide-wrapper\">\n  \u003Ch2 id=\"material_title\" class=\"drug-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌治疗用药实用指南：高级别导管原位癌与浸润性导管癌II级\u003C/h2>\n  \u003Cdiv class=\"drug-guide-intro drug-guide-section-bg\">\n    \u003Cp>说起来，针对乳腺疾病的治疗用药，很多人第一反应都是化疗、靶向等大类。但每种药物的成分、用法和注意事项都有关键区别。本文将帮你理清乳腺癌关键用药的7个实用细节，包括服药时间、剂型用法、不良反应及储存等内容，让家人使用这些药品时做到心中有数，放心安全。\u003C/p>\n    \u003Cp>（共细分7类核心用药知识）\u003C/p>\n  \u003C/div>\n\n  \u003C!-- 01 剂型特点与正确服用方法 -->\n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 剂型特点与正确服用方法 🚩\u003C/h2>\n    \u003Cul class=\"drug-guide-list\">\n      \u003Cli>\u003Cstrong>注射剂与口服片剂：\u003C/strong>常见治疗方案包括化疗注射剂（如多柔比星、紫杉醇）、靶向注射剂（如曲妥珠单抗、帕妥珠单抗），以及口服片剂（如奈拉替尼、溴隐亭等）。不同剂型的服药方式完全不同。\n        \u003Cul>\n          \u003Cli>注射剂必须由专业人员在医院静脉或皮下注射，无法自行在家使用。\u003C/li>\n          \u003Cli>口服片剂请用250ml-300ml左右温水送服，保证完整吞咽，不可掰碎、嚼服，尤其奈拉替尼等肠溶片。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>特殊剂型说明：\u003C/strong>奈拉替尼一般为薄膜包衣片，必须整片吞服，避免破坏药物缓释特性。\u003C/li>\n      \u003Cli>正确做法：每天同一时间用药，保持规律，尤其口服药物建议早晨空腹或餐后30分钟内服。\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\n  \u003C!-- 02 用药时间与饮食关系 -->\n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 用药时间与饮食关系 ⏰\u003C/h2>\n    \u003Cul class=\"drug-guide-list\">\n      \u003Cli>\u003Cstrong>口服药物（如奈拉替尼、溴隐亭）：\u003C/strong>\n        \u003Cul>\n          \u003Cli>奈拉替尼必须在饭前1小时或饭后2小时服用，能减轻胃肠道刺激。\u003C/li>\n          \u003Cli>溴隐亭适合随餐服用，减少恶心。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n      \u003Cli>建议用水服药，不要用茶水、果汁、乳制品。\u003C/li>\n      \u003Cli>如忘记服药，只补一次，不要加倍服用、不得累计漏服。\u003C/li>\n      \u003Cli>部分化疗药物需配合抗吐药（如昂丹司琼）一起使用，按照医嘱提前半小时服用。\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\n  \u003C!-- 03 药品作用机制简析 -->\n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 药品作用机制简析 🧬\u003C/h2>\n    \u003Cul class=\"drug-guide-list\">\n      \u003Cli>\u003Cstrong>奈拉替尼：\u003C/strong>为口服小分子不可逆ErbB受体抑制剂，主要阻断HER2信号通路，抑制肿瘤细胞增殖。\u003C/li>\n      \u003Cli>\u003Cstrong>曲妥珠单抗、帕妥珠单抗：\u003C/strong>属HER2靶向人源化单克隆抗体，通过结合肿瘤细胞表面HER2从而阻断生长。\u003C/li>\n      \u003Cli>\u003Cstrong>化疗药物：\u003C/strong>多柔比星、紫杉醇等通过干扰细胞分裂相关蛋白与DNA结构，使肿瘤细胞无法继续增殖。\u003C/li>\n      \u003Cli>\u003Cstrong>溴隐亭：\u003C/strong>主要作用为降低体内泌乳素水平，属于多巴胺受体激动剂。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drug-guide-mechanism-tip\">\n      \u003Cspan>这些机制仅用于解释药物如何起效，无需关注疾病本身，重在把握药品使用重点。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 04 剂量与特殊人群用药调整 -->\n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 剂量及特殊人群用药调整 🎯\u003C/h2>\n    \u003Cul class=\"drug-guide-list\">\n      \u003Cli>\u003Cstrong>成人标准用量：\u003C/strong>具体药品剂量需遵医嘱（如奈拉替尼常规起始剂量每日240mg整片吞服）。\u003C/li>\n      \u003Cli>\u003Cstrong>老年人：\u003C/strong>肝肾功能减弱时部分药物须减量；紫杉醇、奈拉替尼如有肝肾损伤需调整剂量，遵照医生方案。\u003C/li>\n      \u003Cli>\u003Cstrong>孕妇与哺乳期：\u003C/strong>孕妇严格禁用多柔比星、紫杉醇等化疗药物；奈拉替尼建议停药或避免哺乳期服用。\u003C/li>\n      \u003Cli>\u003Cstrong>肝肾功能减退者：\u003C/strong>曲妥珠单抗、奈拉替尼用量需根据肝肾检查调整；肾功能障碍者慎用溴隐亭。\u003C/li>\n      \u003Cli>正确做法：首次使用前必须检测肝肾功能，儿童患者不推荐使用上述药物。\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\n  \u003C!-- 05 药物相互作用要点提示 -->\n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 药物相互作用要点提示 🔄\u003C/h2>\n    \u003Cul class=\"drug-guide-list\">\n      \u003Cli>\u003Cstrong>奈拉替尼：\u003C/strong>不能与强效CYP3A4抑制/诱导剂（如酮康唑、利福平）同服，避免影响代谢。\u003C/li>\n      \u003Cli>\u003Cstrong>多柔比星与紫杉醇：\u003C/strong>合用时需严格控制先后顺序，避免毒性叠加；曲妥珠单抗、帕妥珠单抗与化疗可联合使用，但需要专科评估。\u003C/li>\n      \u003Cli>\u003Cstrong>溴隐亭：\u003C/strong>与抗精神病药（如氯丙嗪）同用时药效降低；不可与麦角类药物等增强副作用。\u003C/li>\n      \u003Cli>\u003Cstrong>饮食因素：\u003C/strong>口服奈拉替尼期间忌葡萄柚、柚子类水果（会升高血药浓度）。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drug-guide-interaction-tip\">\n      \u003Cspan>服药过程中务必告知医生目前所有用药，包括中药、保健品，防止隐形相互作用。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 06 常见不良反应识别与处理 -->\n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见不良反应识别与处理 🚦\u003C/h2>\n    \u003Cul class=\"drug-guide-list\">\n      \u003Cli>\u003Cstrong>奈拉替尼：\u003C/strong>最常见为腹泻（发生率约60%），可提前使用止泻药（如洛哌丁胺）；轻度腹泻可多饮水、少量多餐；如持续3次及以上，需联系医生。\u003C/li>\n      \u003Cli>\u003Cstrong>化疗药物（多柔比星、紫杉醇）：\u003C/strong>可出现恶心呕吐（约80%）、白细胞减少（20-50%）、脱发，需定期查血象并对症调节。\u003C/li>\n      \u003Cli>\u003Cstrong>曲妥珠单抗：\u003C/strong>可能引发心脏毒性，临床研究显示发生率约3-7%，定期监测心功能。\u003C/li>\n      \u003Cli>\u003Cstrong>溴隐亭：\u003C/strong>偶见头晕、低血压、恶心等，通过餐中服药或分次递增用量缓解。\u003C/li>\n      \u003Cli>【正确做法】出现轻度不良反应时临时停药1天，补充水分、观察症状。如不缓解或出现发热、咳嗽等必须就医。\u003C/li>\n    \u003C/ul>\n    \u003C!-- 典型用药案例1 -->\n    \u003Cdiv class=\"drug-guide-case\">\n      \u003Cspan class=\"drug-guide-case-icon\">🔎\u003C/span>\n      \u003Cspan>临床上，患者服用奈拉替尼后出现腹泻，通过早期配合止泻药得以缓解且未影响治疗。\u003C/span>\n    \u003C/div>\n    \u003C!-- 典型用药案例2 -->\n    \u003Cdiv class=\"drug-guide-case\">\n      \u003Cspan class=\"drug-guide-case-icon\">🔎\u003C/span>\n      \u003Cspan>有患者化疗期间出现白细胞降低，及时补充粒细胞生长因子后安全度过治疗期。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 07 药品储存方法与有效期管理 -->\n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 药品储存方法与有效期管理 📦\u003C/h2>\n    \u003Cul class=\"drug-guide-list\">\n      \u003Cli>\u003Cstrong>储存温度：\u003C/strong>奈拉替尼需在25℃以下避光保存，切勿冷冻，化疗注射剂按药品标签冷藏或避光管理。\u003C/li>\n      \u003Cli>\u003Cstrong>湿度控制：\u003C/strong>片剂及胶囊应干燥、密封，勿暴露于浴室、厨房潮湿环境。\u003C/li>\n      \u003Cli>\u003Cstrong>开封后管理：\u003C/strong>奈拉替尼开瓶后2个月内用完；曲妥珠单抗、化疗针剂配制后4小时内必须用完。\u003C/li>\n      \u003Cli>过期、变色或有异味药品请直接丢弃，不可自行服用加工。\u003C/li>\n      \u003Cli>饮用水、果汁不可用作储存溶媒，仅限使用药品指定稀释液体。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drug-guide-store-tip\">\n      \u003Cspan>药品存放建议采用单独储药柜，远离儿童、宠物和厨房高温区。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 08 漏服与过量应对技巧 -->\n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏服、过量应对技巧 🚑\u003C/h2>\n    \u003Cul class=\"drug-guide-list\">\n      \u003Cli>\u003Cstrong>漏服：\u003C/strong>如忘记服一次奈拉替尼，应尽快补服；但如已到下一次服药时间，直接跳过不补。\u003C/li>\n      \u003Cli>\u003Cstrong>过量：\u003C/strong>奈拉替尼、溴隐亭过量服用有可能出现严重腹泻、头晕、低血压等，务必立即联系医生或就近急救。\u003C/li>\n      \u003Cli>\u003Cstrong>操作建议：\u003C/strong>不要尝试自行催吐或服用抗药品，不要加倍补服以弥补漏服。\u003C/li>\n      \u003Cli>化疗注射剂过量仅能在医院抢救，不可自行处理。\u003C/li>\n    \u003C/ul>\n    \u003C!-- 用药案例3（唯一性保证） -->\n    \u003Cdiv class=\"drug-guide-case\">\n      \u003Cspan class=\"drug-guide-case-icon\">🔎\u003C/span>\n      \u003Cspan>临床有患者溴隐亭漏服一剂，并未补服，下次按原时段服药，全程未出现不良反应。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 09 药品科普总结与再提醒 -->\n  \u003Cdiv class=\"drug-guide-summary drug-guide-section-bg\">\n    \u003Ch2 class=\"drug-guide-summary-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">用药关键总结 🌟\u003C/h2>\n    \u003Cp>乳腺癌治疗药物类型繁多，包括化疗、靶向及口服药物，不同剂型均有专属的用法与注意事项。奈拉替尼每日固定时刻服用，曲妥珠单抗需住院注射，溴隐亭餐中服减少副作用，所有药品均不得随意更改剂量或自行中断。\u003C/p>\n    \u003Cp>最需要关注的是服药方式和不良反应，一旦出现明显副作用，切勿自行处理，应及时就医。储存药品时请注意温度和湿度，远离厨房和儿童，过期药品严禁服用。\u003C/p>\n    \u003Cp>最后，合理使用药物，遵循专业医师建议，远离用药风险，这些细节更值得家人反复提醒、牢记和执行。\u003C/p>\n  \u003C/div>\n\n  \u003C!-- 参考文献引用 -->\n  \u003Cdiv class=\"drug-guide-ref drug-guide-section-bg\">\n    \u003Ch3 class=\"drug-guide-ref-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">引用文献 📚\u003C/h3>\n    \u003Cul>\n      \u003Cli>Murphy, C. G., & Moy, B. (2010). HER2-Positive Breast Cancer: Current Management of Early, Advanced, and Recurrent Disease. \u003Cem>Current Problems in Cancer\u003C/em>, 34(5), 187–210. https://doi.org/10.1016/j.currproblcancer.2010.08.001\u003C/li>\n      \u003Cli>Cortes, J., et al. (2019). Neratinib in Early-Stage Breast Cancer: Risk Mitigation Strategies for Diarrhea. \u003Cem>Oncologist\u003C/em>, 24(5), 654-662. https://doi.org/10.1634/theoncologist.2018-0440\u003C/li>\n      \u003Cli>Baselga, J., et al. (2012). Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer. \u003Cem>The New England Journal of Medicine\u003C/em>, 366(2), 109-119. https://doi.org/10.1056/NEJMoa1113216\u003C/li>\n      \u003Cli>Sharma, A., & Tandon, V. R. (2022). Drug interactions and precautions in breast cancer chemotherapy. \u003Cem>Indian Journal of Medical Research\u003C/em>, 156, 63-70.\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n/* 独立全局样式 - 全局类名 drug-guide-XXX，避免嵌套影响其他页面 */\n.drug-guide-wrapper {\n  font-family: \"Microsoft Yahei\", Arial, sans-serif;\n  max-width: 860px;\n  margin: 32px auto;\n  background: #fafbfc;\n  padding: 32px 40px 36px 40px;\n  border-radius: 18px;\n  box-shadow: 0 2px 16px rgba(110,133,180,0.08), 0 0px 1px #d4dde6;\n  box-sizing: border-box;\n}\n.drug-guide-title {\n  font-size: 38px;\n  font-weight: bold;\n  margin-bottom: 38px;\n  padding-bottom: 12px;\n  letter-spacing: 2px;\n  border-bottom: 2px solid #e8effc;\n  color: #25578A;\n  background: linear-gradient(115deg,#e8f0fa 0%,#fff 100%);\n}\n.drug-guide-section {\n  margin-bottom: 38px;\n  border-radius: 12px;\n  overflow: hidden;\n  box-sizing: border-box;\n}\n.drug-guide-section-bg {\n  background: linear-gradient(112deg,#eef3fa 90%,#fff 100%);\n  padding: 24px 28px;\n  margin-bottom: 30px;\n}\n\n.drug-guide-subtitle {\n  font-size: 28px;\n  color: #2265b1;\n  font-weight: 700;\n  margin-bottom: 22px;\n  background: linear-gradient(90deg,#e2e9fa 80%,#f5fafc 100%);\n  box-sizing: border-box;\n  padding: 8px 14px 6px 14px;\n  border-radius: 8px;\n}\n.drug-guide-list {\n  margin: 0 0 12px 18px;\n  padding: 0;\n  color: #34536f;\n  font-size: 19px;\n  line-height: 1.82;\n}\n.drug-guide-list > li {\n  margin-bottom: 13px;\n}\n.drug-guide-list strong {\n  color: #174665;\n  font-weight: 800;\n}\n.drug-guide-mechanism-tip,\n.drug-guide-interaction-tip,\n.drug-guide-store-tip {\n  font-size: 16px;\n  background: #e3f3fa;\n  border-left: 4px solid #89b9dc;\n  margin: 12px 0 0 0;\n  padding: 8px 16px;\n  border-radius: 6px;\n  color: #226fa4;\n  font-style: italic;\n}\n\n.drug-guide-case {\n  font-size: 17px;\n  color: #224e7e;\n  background: #f6faff;\n  border-left: 4px solid #c1d9f2;\n  margin: 8px 0 0 12px;\n  padding: 6px 16px;\n  border-radius: 5px;\n  display: flex;\n  align-items: flex-start;\n}\n.drug-guide-case-icon {\n  font-size: 22px;\n  margin-right: 8px;\n  color: #3788e0;\n}\n\n.drug-guide-summary-title {\n  font-size: 26px;\n  font-weight: bold;\n  color: #25578A;\n  background: linear-gradient(90deg,#e2e9fa 80%,#f5fafc 100%);\n  padding: 8px 14px 6px 14px;\n  border-radius: 8px;\n  margin-bottom: 18px;\n}\n.drug-guide-summary {\n  font-size: 20px;\n  color: #244970;\n  line-height: 1.9;\n}\n\n.drug-guide-ref-title {\n  font-size: 21px;\n  color: #2678be;\n  font-weight: 700;\n  padding-bottom: 6px;\n}\n.drug-guide-ref {\n  font-size: 16px;\n  color: #56769d;\n  padding-left: 10px;\n}\n.drug-guide-ref ul {\n  margin: 0;\n  padding-left: 20px;\n}\n.drug-guide-ref li {\n  margin-bottom: 9px;\n}\n\u003C/style>\n","\u003Cdiv class=\"drug-guide-wrapper\">\n  \u003Ch2 id=\"material_title\" class=\"drug-guide-title\" style=\"color: rg",566,"2025-08-21 15:22:32","乳腺癌, 化疗药物, 靶向药物, 用药指南, 剂量调整, 不良反应, 患者教育","了解乳腺癌常用药物的用法与注意事项，包括化疗、靶向药物的剂型与不良反应，帮助患者及家属安全用药，增强治疗效果。","2025-08-25 09:22:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]